OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BIOTEST AG VZ O.N./  DE0005227235  /

Xetra
11/29/2023  10:48:04 AM Chg. 0.000 Volume Bid10:48:10 AM Ask10:48:04 AM Market Capitalization Dividend Y. P/E Ratio
31.600EUR 0.00% 741
Turnover: 23,271		 31.200Bid Size: 343 31.600Ask Size: 2,565 1.68 bill.EUR 0.09% -

Fundamentals

  FY 2021 Growth (1Y)
Per Share  
Earnings per Share: -1.59 EUR 103.85%
EPS Diluted: -1.59 EUR 103.85%
Revenues per Share: 13.03 EUR 6.48%
Book Value per Share: 9.61 EUR -13.86%
Cash Flow per Share: 0.86 EUR -
Dividend per Share: 0.04 EUR 0.00%
Total in mill.  
Revenues: 515.60 EUR 6.48%
Net Income: -63.40 EUR 101.91%
Operating Cash Flow: 33.90 EUR -
Cash and Cash Equivalents: 104.40 EUR -

Valuation Ratios

  Current Latest FY*
P/E Ratio: - -
P/S Ratio: 3.25 2.96
P/BV ratio: 4.41 4.02
P/CF Ratio: 49.49 45.06
PEG: -0.26 -
Earnings Yield: -3.75% -4.12%
Dividend Yield: 0.09% 0.10%
Market Capitalization  
Market Capitalization: 1.68 bill. EUR 1.53 bill. EUR
Free Float Market Cap.: 838.93 mill. EUR 763.74 mill. EUR
Market Cap. / Employee: 426,500.4575 EUR 388,276.3599 EUR
Shares Outstanding: 19.79 mill.  
 

Profitability

Gross Profit Margin: 15.65%
EBIT Margin: -9.14%
Net Profit Margin: -12.30%
Return on Equity: -16.67%
Return on Assets: -5.74%

Financial Strength

Liquidity I / Cash Ratio: 98.12%
Liquidity II / Quick Ratio: 198.97%
Liquidity III / Current Ratio: 490.79%
Debt / Equity Ratio: 190.27%
Dynam. Debt / Equity Ratio: 2,135.10%

Efficiency

Employees: 1,967
Personal Expenses / Employee: 83,019.83 EUR
Revenues / Employee: 262,125.06 EUR
Net Income / Employee: -32,231.83 EUR
Total Assets / Employee: 561,362.48 EUR
 
* Fiscal Year End: 12/31/2021
Accounting Standard: IFRS
Currency: EUR